// App-Quantinova.ai

FRI-357 : Does Sitagliptin Affect the Rate of Osteoporotic Fractures in Type-2 Diabetes? Population-Based Cohort Study

Researchers

Presenter

  • Robert G Josse

Principal Investigators

  • Mu Lin

  • Dean Eurich

Medical Centers

  • University of Alberta, Edmonton, AB, Canada

  • University of Alberta,

Locations

  • Canada

Companies

  • N/A

Study Components

Therapeutic Area

  • Endocrine/metabolic Diseases (ME)

Disease

  • Type 2 diabetes mellitus

  • Osteoporosis

  • Diabetes

Biomarkers

  • Hemoglobin A1c

Drug/Treatment

  • Thiazolidinedione

  • sulfonylureas

  • Sitagliptin

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Interim

Copyright © 2026. QuantiNova All rights reserved